PT  - JOURNAL ARTICLE
AU  - Chen, Xiaofeng
AU  - Wu, Xiaofeng
AU  - Wu, Hao
AU  - Gu, Yanhong
AU  - Shao, Yang
AU  - Shao, Qianwen
AU  - Zhu, Feipeng
AU  - Li, Xiao
AU  - Qian, Xiaofeng
AU  - Hu, Jun
AU  - Zhao, Fengjiao
AU  - Mao, Weidong
AU  - Sun, Jing
AU  - Wang, Jian
AU  - Han, Gaohua
AU  - Li, Changxian
AU  - Xia, Yongxiang
AU  - Seesaha, Poshita Kumari
AU  - Zhu, Dongqin
AU  - Li, Huajun
AU  - Zhang, Junling
AU  - Wang, Guoqiang
AU  - Wang, Xuehao
AU  - Li, Xiangcheng
AU  - Shu, Yongqian
TI  - Camrelizumab plus gemcitabine and oxaliplatin (GEMOX) in patients with advanced biliary tract cancer: a single-arm, open-label, phase II trial
AID  - 10.1136/jitc-2020-001240
DP  - 2020 Nov 01
TA  - Journal for ImmunoTherapy of Cancer
PG  - e001240
VI  - 8
IP  - 2
4099  - http://jitc.bmj.com/content/8/2/e001240.short
4100  - http://jitc.bmj.com/content/8/2/e001240.full
SO  - J Immunother Cancer2020 Nov 01; 8
AB  - Markup server — Error Not Found The page you were trying to reach could not be found. Please check the address for the page you were trying to reach. If you believe you have reached this page in error, you may contact us with any questions.